Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. in April, 2016 for $3,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI086135-05 | Phase II | 3,000,000 | April 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. for $2,789,079.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI086135-02 | Phase II | 2,789,079 | ||||||||
A STTR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $300,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI093032-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. for $1,499,927.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CA130076 | Phase II | 1,499,927 | ||||||||
A SBIR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $199,757.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110035 | Phase I | 199,757 | ||||||||
A SBIR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $297,326.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI086135-01 | Phase I | 297,326 |